文献速递血液净化与透析

血液透析试验中心血管结局优先级的国际调查

Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

该国际在线调查纳入127名患者/照护者和549名健康专业人员,评估10项心血管结局的重要性。除「瓣膜置换」外所有结局均被评為至关重要,心源性猝死、心肌梗死、卒中和心力衰竭被患者和健康专业人员一致列为最重要结局。

要点

  • 患者和健康专业人员均认为所有心血管结局至关重要,但一致优先考虑心源性猝死、心肌梗死、卒中和心力衰竭。
  • 调查涵盖53个国家,患者/照护者占19%,健康专业人员占81%。
  • 「瓣膜置换」是唯一未被所有参与者评为至关重要的结局。

核心结论

  • 患者和健康专业人员认为所有心血管结局均至关重要,但一致将心源性猝死、心肌梗死、卒中和心力衰竭列为所有血液透析试验应测量的最重要结局。

研究设计与样本

  • 国际在线调查,参与者对10项心血管结局进行9点Likert量表评分(7-9分为至关重要)和最佳-最差量表相对重要性评估,并对评论进行主题分析。

主要发现

  • 参与者包括127名(19%)患者/照护者和549名(81%)健康专业人员,来自53个国家。
  • 除「瓣膜置换」外,所有心血管结局均被所有参与者评为至关重要(Likert 7-9)。
  • 患者/照护者将心源性猝死、心肌梗死、卒中和心力衰竭列为最重要结局,中位Likert评分为9。
  • 患者/照护者上述四项结局的平均偏好评分分别为6.2(95%CI 4.8-7.5)、5.9(4.6-7.2)、5.3(4.0-6.6)和4.9(3.6-6.3)。
  • 健康专业人员也将同样的四项结局列为最重要。

临床怎么用

  • 建议在血液透析试验的核心结局集中纳入心源性猝死、心肌梗死、卒中和心力衰竭作为优先测量的心血管结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiovascular disease (CVD) is a major contributor to morbidity and mortality in people on hemodialysis (HD). Cardiovascular outcomes are reported infrequently and inconsistently across trials in HD. This study aimed to identify the priorities of patients/caregivers and health professionals (HPs) for CVD outcomes to be incorporated into a core outcome set reported in all HD trials. METHODS: In an international online survey, participants rated the absolute importance of 10 cardiovascular outcomes (derived from a systematic review) on a 9-point Likert scale, with 7-9 being critically important. The relative importance was determined using a best-worst scale. Likert means, medians and proportions and best-worst preference scores were calculated for each outcome. Comments were thematically analyzed. RESULTS: Participants included 127 (19%) patients/caregivers and 549 (81%) HPs from 53 countries, of whom 530 (78%) completed the survey in English and 146 (22%) in Chinese. All but one cardiovascular outcome ('valve replacement') was rated as critically important (Likert 7-9) by all participants; 'sudden cardiac death', 'heart attack', 'stroke' and 'heart failure' were all rated at the top by patients/caregivers (median Likert score 9). Patients/caregivers ranked the same four outcomes as the most important outcomes with mean preference scores of 6.2 (95% confidence interval 4.8-7.5), 5.9 (4.6-7.2), 5.3 (4.0-6.6) and 4.9 (3.6-6.3), respectively. The same four outcomes were ranked most highly by HPs. We identified five themes underpinning the prioritization of outcomes: 'clinical equipoise and potential for intervention', 'specific or attributable to HD', 'severity or impact on the quality of life', 'strengthen knowledge and education', and 'inextricably linked burden and risk'. CONCLUSIONS: Patients and HPs believe that all cardiovascular outcomes are of critical importance but consistently identify sudden cardiac death, myocardial infarction, stroke and heart failure as the most important outcomes to be measured in all HD trials.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. O'Lone E, Howell M, Viecelli AK, et al. Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020. PMID: 32040154. doi:10.1093/ndt/gfaa008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。